VANCOUVER: mCloud Technologies Corp. (TSX-V: MCLD, MCLD.DB) (OTCQB: MCLDF) (mCloud or the Company), a leading provider of asset management solutions combining IoT, cloud computing, artificial intelligence (AI), and analytics, announced it is embedding advanced sensing technology from NYCE Sensors Inc. (NYCE), an industry-leading provider of IoT solutions for commercial building applications, into its AssetCare solutions for Smart Facilities.
Recent scientific research has shown that proper ventilation and airflow can play an important role in reducing the spread of airborne contaminants and pathogens, said Barry Po, Ph.D., mCloud's President, Smart Facilities. Today we are tracking CO2 levels and air quality in over 3,000 buildings, continuously improving our AI to make real-time decisions about how to optimize HVAC runtime, improve building comfort, and ensure building occupants avoid the impact of sick building syndrome.
Based on the demand we are seeing from our existing customers for solutions that improve building safety, we expect this integration of NYCE technology to expand our capacity to connect to even more assets per building, with higher monthly recurring revenue per connected HVAC unit, Po added. Our 2020 plan originally saw us connecting at least 28,000 new assets in thousands of buildings across six countries through energy savings alone, and the addition of digital air quality capabilities will enable us to drive that growth even further.
The Center for Sustainable Systems at the University of Michigan estimates there are at least 5.6 million commercial buildings covering more than 87 billion square feet of floor space in the United States alone, accounting for 17% of all CO2 greenhouse gas emissions nationwide in 2018. In addition, they estimated that Volatile Organic Compounds (VOCs) are found in concentrations two to five times greater indoors than in nature, leading to indoor air quality issues that include eye, nose, and throat irritation, headaches and nausea, and even extreme effects such as cancer or nervous system damage. (PRN/11 months ago)